Delivery Order SPE2DE24D0021-SPE2D625F2DXP
- Not listed
- Fisher Scientific Company L.L.C. was awarded a $3,099.96 fixed-price delivery order with economic price adjustment on August 11, 2025, to supply PROFILE-V 12 Panel DOA (Drugs of Abuse) Test kits at 25 per package. The contract, which is a child order under a larger vehicle, will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 25, 2025. No set-aside designation was used in this award. The funding source is identified as the Medical Supply Chain within the...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,722.20 by the Defense Medical Supply Chain federal agency for the procurement of PROFILE-V 12 Panel DOA (Drugs of Abuse) Test kits, 25 per pack. This fixed-price delivery order with economic price adjustment was awarded on July 18, 2025, with an ultimate completion date of July 25, 2025, and will be performed in Pittsburgh, Pennsylvania. The award represents a child contract, indicating it falls under a larger...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,722.20 on September 22, 2025, by the Defense Department's Medical Supply Chain division to supply Profile-V 12-panel DOA (Drugs of Abuse) test kits, with 25 units per package. This fixed-price contract with economic price adjustment authority has an ultimate completion date of September 29, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was made through open competition with no set-aside designation,...
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract valued at $8,266.56 for the procurement of PROFILE-V 12 Panel DOA (Drugs of Abuse) Test kits, 25 per pack, on July 24, 2025. The contract carries a fixed-price structure with economic price adjustment provisions and is scheduled for completion by July 31, 2025. This is an uncompensated delivery order with no set-aside designation, reflecting Fisher Scientific's competitive standing in open federal procurement. The...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $6,199.92 on July 21, 2025, for the procurement of Profile-V 12 Panel DOA (Drugs of Abuse) Test kits, 25 per pack (Contract Number 4568847894). The contract is fixed price with economic price adjustment provisions and carries an ultimate completion date of July 28, 2025. Performance will occur in Pittsburgh, Pennsylvania, and the award was made without a set-aside designation, indicating open competition. The funding federal...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $6,199.92 on September 15, 2025, for the procurement of PROFILE-V 12 panel DOA (drugs of abuse) test kits, 25 per package. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of September 29, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was issued by the Medical Supply Chain within the Defense enterprise and represents an open competition procurement with...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $4,477.72 by the Medical Supply Chain, a defense-focused federal agency, for the procurement of Profile-V 12 Panel DOA (Drugs of Abuse) test kits (25 per package). This fixed-price delivery order with economic price adjustment authority was issued on September 5, 2025, with an ultimate completion date of September 12, 2025. The contract represents a child award under a larger vehicle structure and will be performed at...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,722.20 for the procurement of Profile-V 12-panel DOA (drugs of abuse) test kits, 25 per package. This fixed-price contract with economic price adjustment was awarded on May 27, 2025, with an ultimate completion date of June 3, 2025. The contract is being funded by the Medical Supply Chain, a defense-focused federal agency, with performance to be completed in Pittsburgh, Pennsylvania. This award represents a child...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,916.82 on September 19, 2025, for the procurement of Profile-V 11 Panel DOA (Drugs of Abuse) test kits, 25 per package. This is a fixed-price contract with economic price adjustment provisions and represents a child order under a larger contract vehicle. The contract carries no set-aside designation, indicating open competition. The place of performance is Pittsburgh, Pennsylvania, and the contract is scheduled for...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,555.76 for the procurement of a PROFILE-V 11PNL DOA TEST 25/PK (a drug of abuse screening test product) on September 3, 2025. This fixed-price delivery order with economic price adjustment has an ultimate completion date of September 10, 2025 and will be performed in Pittsburgh, Pennsylvania. The contract was awarded without a set-aside designation, indicating open competition. The funding source is the Medical Supply...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F2DXPDelivery Order
Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,277.88 for PROFILE-V 11 Panel DOA (Drugs of Abuse) Test kits, 25 per pack, with an ultimate completion date of September 5, 2025. This fixed-price contract with economic price adjustment was awarded on August 28, 2025, without a set-aside designation, indicating open competition. The award supports the Medical Supply Chain within the Department of Defense and will be performed in Pittsburgh, Pennsylvania. This delivery order represents a child contract, suggesting it derives from a larger contract vehicle or blanket purchase agreement. The contract aligns with Fisher Scientific's established role as a critical supplier of laboratory and medical testing solutions to federal agencies. Given Fisher Scientific's extensive history providing specialized testing reagents and supplies—particularly its notable Blanket Purchase Agreement with the Department of Veterans Affairs for toxicology and drugs of abuse testing—this award reflects the company's recognized expertise in providing quality assurance testing products for federal healthcare and defense operations. The relatively modest contract value indicates this delivery order is likely one of several routine procurements under an existing agreement to maintain stock levels of essential drug screening test kits.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/28/25 |